bioAffinity Technologies, Inc. Stock
Equities
BIAF
US09076W1099
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.37 USD | -1.66% | -14.75% | +61.17% |
Financials (USD)
Sales 2022 | 0 | Sales 2023 | 2.53 | Capitalization | 13.97M |
---|---|---|---|---|---|
Net income 2022 | -8M | Net income 2023 | -7M | EV / Sales 2022 | 464,207,162 x |
Net cash position 2022 | 11.16M | Net cash position 2023 | 1.24M | EV / Sales 2023 | 5,026,702 x |
P/E ratio 2022 |
-0.88
x | P/E ratio 2023 |
-1.62
x | Employees | 14 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 65.27% |
Latest transcript on bioAffinity Technologies, Inc.
1 day | -1.66% | ||
1 week | -14.75% | ||
Current month | +17.33% | ||
1 month | +13.40% | ||
3 months | +44.51% | ||
6 months | +59.06% | ||
Current year | +61.17% |
Managers | Title | Age | Since |
---|---|---|---|
Maria Zannes
FOU | Founder | 68 | 14-03-25 |
Director of Finance/CFO | 45 | 23-04-30 | |
David Elzi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Girgenti
CHM | Chairman | 78 | 14-02-28 |
Peter Knight
BRD | Director/Board Member | 73 | 18-04-30 |
Stuart Diamond
BRD | Director/Board Member | 63 | 21-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 2.37 | -1.66% | 94,849 |
24-04-25 | 2.41 | -1.63% | 119,466 |
24-04-24 | 2.45 | -5.41% | 112,818 |
24-04-23 | 2.59 | -13.67% | 403,666 |
24-04-22 | 3 | +7.91% | 245,574 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+61.17% | 27.29M | |
+0.89% | 12.8B | |
-10.29% | 7.61B | |
+1.78% | 5.41B | |
-1.16% | 4.51B | |
+5.74% | 4.49B | |
-50.70% | 3.29B | |
+12.21% | 2.73B | |
-16.13% | 2.02B | |
-11.50% | 1.73B |
- Stock Market
- Equities
- BIAF Stock